[go: up one dir, main page]

GB201808821D0 - Treatment of metabolic disorders - Google Patents

Treatment of metabolic disorders

Info

Publication number
GB201808821D0
GB201808821D0 GBGB1808821.1A GB201808821A GB201808821D0 GB 201808821 D0 GB201808821 D0 GB 201808821D0 GB 201808821 A GB201808821 A GB 201808821A GB 201808821 D0 GB201808821 D0 GB 201808821D0
Authority
GB
United Kingdom
Prior art keywords
treatment
metabolic disorders
metabolic
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1808821.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabogen AB
Original Assignee
Metabogen AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabogen AB filed Critical Metabogen AB
Priority to GBGB1808821.1A priority Critical patent/GB201808821D0/en
Publication of GB201808821D0 publication Critical patent/GB201808821D0/en
Ceased legal-status Critical Current

Links

GBGB1808821.1A 2018-05-30 2018-05-30 Treatment of metabolic disorders Ceased GB201808821D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1808821.1A GB201808821D0 (en) 2018-05-30 2018-05-30 Treatment of metabolic disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1808821.1A GB201808821D0 (en) 2018-05-30 2018-05-30 Treatment of metabolic disorders

Publications (1)

Publication Number Publication Date
GB201808821D0 true GB201808821D0 (en) 2018-07-11

Family

ID=62812257

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1808821.1A Ceased GB201808821D0 (en) 2018-05-30 2018-05-30 Treatment of metabolic disorders

Country Status (1)

Country Link
GB (1) GB201808821D0 (en)

Similar Documents

Publication Publication Date Title
IL273693A (en) Treatment of inflammatory disorders
IL257978A (en) Use of pasteurized akkermansia for treating metabolic disorders
IL267924B (en) Azolopyrimidine for the treatment of cancer-related disorders
IL269302A (en) Pyrimidinyl-pyridyloxy-naphthyl compounds and methods of treating ire1-related diseases and disorders
GB201804514D0 (en) Treatment of pyroptosis
IL275182A (en) Compositions and methods for the treatment of metabolic conditions
IL270781A (en) Treatment of depressive disorders
AU2022221400B2 (en) Methods of treating metabolic disorders with FGF21 variants
GB201805100D0 (en) Treatment of sarcopenic diseases
GB201612043D0 (en) Composition for treatment of disorders
GB201607388D0 (en) Treatment of impulsivity-related disorders
GB201804515D0 (en) Treatment of necroptosis
LT3458067T (en) Treatment of neurological disorders
ZA202002910B (en) Treatment of skin disorders
EP3658218A4 (en) Treatment of eye disorders
GB201808821D0 (en) Treatment of metabolic disorders
GB201604359D0 (en) Treatment of tissue disorders
SG11202007642RA (en) Treatment of disorders with tasimelteon
ZA202004110B (en) Compositions and methods for the treatment of metabolic conditions
HK40045533A (en) Treatment of disorders with tasimelteon
HK40036504A (en) Treatment of inflammatory disorders
GB201811912D0 (en) Treatment of disease
GB201811911D0 (en) Treatment of disease
GB201808723D0 (en) Treatment of hyperproliferative disorders
GB201810974D0 (en) Treatment of disease

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)